Research Article (Open access) |
---|
Int. J. Life. Sci. Scienti. Res., 4(1): 1620-1626, January 2018
Genotoxic Study of Chewing Leaf Tobacco in Swiss Albino Mice
Ashoka CH 1*, Mohammed S Mustak2
“*Address For correspondence”:Ashoka CH, Assistant Professor, Department of
Zoology, Government Science College, Nrupathunga
Road, Bangalore -560001, Karnataka, India
ABSTRACT-
The tobacco plant Nicotiana has probably been
responsible for more deaths than any other herb as it is market driven
commodity of economic benefit. While the majority will likely be killed by use
of cigarettes, tobacco use in other forms also contributes to worldwide
morbidity and mortality. Chewing leaf tobacco is less used now as the ban is
imposed on it. We tested the genotoxic potential of chewing leaf tobacco using in vivo cytogenetic tests- peripheral
blood micronucleus test, and sperm abnormality assay. Three doses of tobacco
viz., 3%, 5%, and 10% were given for 14 days. Cyclophosphamide,
an indirect acting clastogen was used as positive
control agent and it was injected intra-peritoneally
to the animals only once. Double distilled water was used as negative control.
The frequency of micronucleated normochromatic
erythrocytes (MNNCE) was increased in tobacco treated mice with the maximum MN
being induced in NCEs at 10% dose. All three tobacco doses used in this study,
induced significant abnormal sperms compared to controls (P<0.05). The
chewing leaf tobacco at a certain concentration is genotoxic.
Keywords: Chewing Leaf
tobacco, Peripheral blood micronucleus, Swiss albino mice, Howell–Jolly bodies
INTRODUCTION- The tobacco plant has conquered the world as a powerful drug in
the form of cigarettes, cigars, and pipes
[1,2] Nicotiana varieties originate mainly from South America.
The tobacco plant, Nicotiana, has probably been
responsible for more deaths than any other herb. At present, tobacco smoking is
causing over 3 million deaths a year worldwide, and if current smoking trends
continue the annual mortality will exceed 10 million by around 2030.
Undoubtedly, tobacco is the most important avoidable cause of premature death
and disease in the world [3].
Smokeless tobacco is consumed without
burning the product and can be used orally and through nasal route. Oral
smokeless tobacco products are placed in the mouth, cheek or lip and sucked
(dipped) or chewed. In India, smokeless
tobacco is famous in the form of Gudakhu, Mishri, snuff, chewing tobacco, Masher, Mawa, Sadagura etc. Maybe
tobacco is the only one plant now known the world over for the overall health
burden it causes to public health. And
probably this is the only one plant whose references are made in almost every
life science journals at least once. The
use of smokeless tobacco among women is increasing in India [4]. Tobacco use
is projected to kill one billion people during the21st
century. While the majority will likely be killed by use of cigarettes, tobacco
use in other forms also contributes to worldwide morbidity and mortality [5].
There is evidence that some tobacco and nicotine products may pose
less health hazard than cigarette smoking and so could reduce morbidity and
mortality due to smoking [6].
There is general agreement in the scientific community that the health hazards
from low nitrosamine smokeless tobacco are lower than those of cigarette smoking
on the individual level. With respect to population impact, there is some
concern about attracting new users with reduced risk products into the overall
pool of tobacco users, whose acquired disease risk would then offset the
reduced disease burden among smokers [7].
Micronuclei (MN), also known as Howell–Jolly bodies, were first
identified at the end of the nineteenth century in red cell precursors by
William Howell, an American, and Justin Jolly, a Frenchman [8]. They found small inclusions in the
blood taken from cats and rats. The small inclusions were also observed in the
erythrocytes of peripheral blood from severe anemia patients [9]. The micronucleus (MN) test is
widely used for screening of different agents for their genotoxic potential. It
is a recommended bioassay in the test battery for genotoxicity
evaluation and has become increasingly popular for regulatory acceptance.
Micronucleus in peripheral blood is used as an index for genotoxic potential.
The mouse erythrocyte micronucleus assay has been traditionally carried out
using one or two exposures to the test agent, followed by sampling at two or
three post-exposure times to obtain a sample near the time of the transient
peak of micronucleated polychromatic erythrocytes
(PCEs). [10].
In animals, exposure of males to toxic chemicals and radiation [11,12] can result in wide variety and
combination of reproductive dysfunction such as changes in the sexual behavior,
spermatogenic killing, diminished sperm quantity and
quality, chromosomal defects in germ cells, reduced fertility etc [13,14]. The mouse sperm morphology
test also has potential in identifying chemicals that induce spermatogenic dysfunction and perhaps heritable mutations [15].
To the present date, more
than 4700 different chemicals have been identified in tobacco smoke, ranging
from heavy metals to polycyclic aromatic hydrocarbons to mutagenic
chemicals. “Sadagura”
a smokeless tobacco of Assam has shown genotoxicity
through micronuclei induction and sperm head abnormality [16]. Compared with nonusers of tobacco,
chewing tobacco users in India and snuff users in Sweden have lower sperm
count, concentration, motility, and normal morphology among men seeking
infertility treatment [17].
Thus we employed Sperm abnormality assay for the investigation of genotoxic
effect of chewing leaf tobacco in Swiss albino mice.
MATERIALS
AND METHODS- In the present investigation
we used Swiss albino mice (Mus musculus), bred and
maintained in the institutional animal house of Department of Applied Zoology,
Mangalore University, Mangaluru, Karnataka, India.
The animal studies were conducted after obtaining the approval from the
Institutional Animal Ethical Committee (IAEC) of Mangalore University. Care of
the animals and experimental procedures were conducted as per the guidelines of
CPCSEA (Committee for the Purpose of Control and Supervision of Experimentation
on Animals) India. Animals were housed in polypropylene shoe box cages bedded
with clean, dry paddy husk and kept in air-conditioned room at a temperature of
22± 2◦C and relative humidity 50±15%. They were fed with a standard pelleted diet and water ad libitum.
8-10 weeks old animals of both the sexes with average body weight, 25±2g were
used for the experiments. In each experimental and control groups, five animals
were maintained. Cyclophosphamide (CP, CAS No.
6055-19-2; Batch No. GL3045, Asta Medica
AG Germany), marketed as Endoxan by German Remedies
Ltd, Ponda, India was used as the positive control.
All other chemicals were obtained from MERCK, SRL or HI media, India.
For the present study, three
doses of tobacco viz., 3%, 5%, and 10% were chosen. Different doses were
prepared by homogenizing in mortar and pestle using suitable amount of
distilled water. These doses were administered orally in 0.2 ml quantity for 14
consecutive days. Cyclophosphamide, an indirect
acting clastogen
[18] (CP, 50 mg/kg b w) was used as positive control agent and it
was injected intraperitoneally to the animals only
once. Double distilled water was used as negative control.
The peripheral blood MN
assay was done by using the method of Schlegel and MacGregor
[19]. The blood was drawn from
the tail vein and thin smears were prepared on clean grease free slides. They
were fixed in absolute methanol for 10 minutes. The slides were then stained
with buffered 10 % Giemsa (pH-6.8) taken in vertical couplin jars. Giemsa staining
technique has been shown to give the best results for micronuclei and other
biomarkers. It should be mentioned here that we filtered the buffered Giemsa using Whatman no 1 filter
paper before staining the slides. A thorough washing under the running tap
water was preferably carried out soon after removing from the stain to remove
any stain particles adhering on the blood cells, which would otherwise impede
the scoring of the micronuclei. About 2000 NCE per animal were scanned for the
presence of MN. The number of PCE corresponding to 2000 NCE was also determined
[20].
The animals used for sperm abnormality
assay are those mentioned above, and they were sacrificed after 35 days of last
tobacco treatment. Animals were killed, and the testes were dissected out and
weighed. Both the cauda epididymis
were removed and minced thoroughly in a watch glass containing 1 ml phosphate
buffered saline (pH=7.2), stained with 2% aqueous eosin for about 45 min. Thin
smears were made. Two thousand sperm/
animal were scored from each group for the presence of sperm shape abnormalities
following the criteria of Wyrobek and Bruce [15]. For sperm count, an aliquot
from the sperm suspension was diluted (1:40) with PBS and mixed thoroughly and
counted using the Neubaur counting chamber and the
total sperm count in 8 squares of 1 mm2 was determined and
multiplied by 5×104 to
calculate the number of sperms per epididymis.
Statistical Analysis- The results of the experiments were expressed as the mean %±SEM.
The significance of differences among the groups was assessed using one-way
analysis of variance (ANOVA) test. The mean
between two groups were analyzed by Students t-test. For all analyses
p<0.05 was set as the critical level of significance.
RESULTS AND DISCUSSION- Measuring numbers of micronuclei in mammalian red
blood cells is relatively straight forward because normoblasts
(erythrocyte precursor cells that reside in the bone marrow) expel their nuclei
during red blood cell development, leaving behind any micronuclei that have
formed. It therefore makes an ideal test for the detection of genome
instability in vivo that is minimally invasive and does not
require the death of the animal, meaning that it can easily be incorporated
into a phenotyping screen [21]. Polychromatic erythrocytes in mouse bone marrow
are abundant, easily recognizable, and have a lifetime of ~2 days before
maturing into normochromatic erythrocytes [22].
Table 1: Results of peripheral blood MN test in Swiss albino mice
treated for 14 days with different doses of chewing leaf Tobacco, at different
sampling timings
Treatment/dose
(mg/kg b w) |
Sample time |
Mean%NCE ± SEM |
MN-NCE/ 1000NCE (Individual
data) |
Mean MN in NCE ± SEM |
Dist. Water |
24 h |
97.82±0.11 |
1.5,0.5,0.5,1,1 |
0.80±0.25 |
48 h |
97.87±0.13 |
1,2,1.5,2,1 |
1.50±0.22 |
|
72 h |
98.02±0.08 |
1.5,1,2,1.5,2 |
1.60±0.18 |
|
3% Tobacco |
24 h |
98.02±0.06 |
2,1.5,3.5,2.5,2 |
2.50±0.35a |
48 h |
97.95±0.08 |
1,2.5,1.5,3.5,2 |
2.10±0.43 |
|
72 h |
97.97±0.12 |
1.5,2,2,0.5,2.5 |
1.70±0.33 |
|
5% Tobacco |
24 h |
98.25±0.04 |
2,2.5,1,3,2 |
0.21±0.33a |
48 h |
98.01±0.09 |
4,2.5,2,3,2 |
2.70±0.37 |
|
72 h |
97.99±0.09 |
1.5,2,1.5,2.5,2 |
1.90±0.18 |
|
10 % Tobacco |
24 h |
98.87±0.06 |
4.5,2.5,5,6,3 |
4.20±0.64a |
48 h |
99.27±0.11 |
4.5,3,5.5,5,6 |
4.80±0.40a |
|
72 h |
99.68±0.07 |
3.5,2.5,3,2,2 |
2.60±0.29 |
|
Positive control (CP 50) |
24 h |
98.11±0.10 |
1.5,0.5,1.5,1.5,2 |
1.40±0.24 |
48 h |
98.72±0.06 |
4,4.5,2.5,5,3.5 |
3.90±0.29a |
|
72 h |
98.51±0.06 |
3,4.5,5.5,6,5 |
4.80±0.51a |
NCE- normochromatic
erythrocytes; MN-NCE- micronucleated normochromatic erythrocytes; CP50- Cyclophosphamide
50mg/kg bw; SEM– Standard error of the mean ANOVA
test: t- test; aP<0.05
The frequency of MN NCE
(Table 1 and Fig. 2) was increased in tobacco treated mice with the maximum MN being
induced in NCEs at 10% dose. The MN-NCE in the positive control was significant
only at 48h and 72h. This may be because the positive control was treated for
only once through intraperitoneal route. The highest
dose, 10% tobacco showed MN-NCE at statistically significant levels from the
distilled water control group (Table 1).
Fig. 1 (A-C): Effect of dosing of chewing leaf
tobacco for 14 days on % PCE in peripheral blood in Swiss albino mice at
different sampling times
A dose-dependent decrease in the percentage frequency of PCE was
found at all sampling times (Fig. 1 and Fig. 3). The polychromatic erythrocytes
are not comparable to that found in the bone marrow. In the bone marrow, at
early developmental stages, the ratio of PCE to NCE is more than one. As it
matures, ratio decreases slowly. The ratio of PCE to NCE decreases when an
animal gets exposed to toxic agent or genotoxic compounds either through
environmental contamination or through the emergency medications. In our study,
this effect was more pronounced in 10% tobacco treated group. This indicates
the suppressive effect of higher dose of chewing leaf tobacco on bone marrow
proliferation.
Background Micronuclei (MN) in mammalian cells
serves as a reliable biomarker of genomic instability and genotoxic
exposure [23]. Elevation of MN
is commonly observed in cells bearing intrinsic genomic instability and in
normal cells exposed to genotoxic agents. Tobacco can
cause and increase the rate of nuclear anomalies in both smoking and smokeless
forms compared to healthy controls. Earlier works demonstrated significant
increase in the number of micronucleated
polychromatic erythrocytes (MN-PCE) and decrease in the number of polychromatic
erythrocytes (PCE) in bone marrow of nicotine-treated animals using
micronucleus assay [24].
Others have investigated the in vivo
micronucleus assay as part of a rat cigarette inhalation study and have also
demonstrated that the level of micronuclei
were not increased following cigarette smoke exposure in peripheral blood or bone marrow
samples [25]. The micronuclei
inductions were not significantly increased following 6 weeks of cigarette
smoke exposure [26].
Fig. 3: One PCE among NCEs
Erythrocyte MN represents the consequence of chromosomal
aberrations induced during the preceding mitotic divisions in the erythroblasts [27]. Swiss
albino mice are suitable for in-vivo micronucleus
assay using peripheral blood because the spleen does not remove the micronucleated erythrocytes from the circulation, whereas
rats are not suitable. The frequency of micronucleated
erythrocytes in the peripheral blood of splenectomized
rats can be used as an index of both acute and cumulative chromosomal damage,
while in normal rats the use of peripheral blood for cytogenetic monitoring is
restricted by the selective removal of these micronucleated
cells [28].
Table 2: Effect of chewing leaf tobacco on epididymal
spermatozoa in Swiss albino mice after sub-acute treatment
Drug / Dose |
Hookless |
Banana shaped |
Amorphous |
Folded |
Double Tails |
DoubleHead |
Total |
Percent Abnormal sperms (Mean ±SEM |
Control |
5.40±0.60 |
1.80±0.37 |
16.00±1.48 |
14.00±1.81 |
0.00±0.00 |
1.00±0.44 |
38.20±2.22 |
1.91±0.11 |
3%
tobacco |
10.80±0.86 |
9.80±0.86a |
21.60±1.74 |
18.00±1.48 |
0.20±0.20 |
2.80±0.73 |
63.20±1.85 a |
3.16±0.09 a |
5%
tobacco |
18.80±1.42a |
11.40±0.67a |
25.60±1.77 a |
22.80±1.65 |
0.40±0.24a |
1.60±0.50 |
80.60±2.15 a |
4.03±0.10 a |
10%tobacco |
20.40±2.29a |
12.60±1.20a |
26.40±2.27 a |
26.00±1.51 |
0.40±0.24a |
3.20±0.37 |
89.00±4.70 a |
4.45±0.23 a |
CP 50 |
15.80±1.49a |
28.00±1.22a |
53.80±2.05 a |
16.80±1.39 |
10.4±1.07a |
4.60±0.81a |
129.40±2.15 a |
6.47±0.10 a |
Five
animals in each group; 2000 sperms/animal; ANOVA test,ap < 0.05
For sperm abnormality assay parameters selected are hook less,
banana shaped, amorphous, double tailed, doubled head and folded (Table 2 and
Fig. 4). The data shows that percent abnormality in control group was 1.91± 0.11 and in CP
treated group 6.47±0.10 i.e., CP induced significant frequency of
abnormal sperms. The number of amorphous sperms were very less in controls,
whereas, in treated individuals, they were in significant frequencies.
Statistically, all three tobacco doses used in this study, induced significant
abnormal sperms compared to controls (P <0.05).
Fig. 4: Graph showing different types of sperm shape abnormalities
induced by chewing leaf tobacco in Swiss albino mice. Each group contained five
animals
Daily smoking has shown a steady rise in
defective sperm morphology [29].
Cigarette smoking is associated with lowered sperm density. Vine et al. [30]
calculated that smokers had a 13%–17% reduction in sperm concentration compared
with nonsmokers [30]. Smokeless or
non-combusted oral tobacco use as a substitute for cigarette smoking has been
gaining greater interest and attention by the public health community and the
tobacco industry. A study by
Kumari et al.
[31] demonstrated
that chronic exposure of mice for six months to 3% pan masala
with tobacco (a South Asian product similar to gutkha)
in the diet produced adverse reproductive outcomes including reductions in spermatid count, mature sperm count, and sperm production [31]. Abnormal
spermatozoa have also been reported in tobacco chewing sub-fertile males. The
adverse impact of tobacco chewing on semen parameters was evident even with
mild chewers, but with the intensive chewing practice, phenotypes of sperms,
mainly defect in the head and cytoplasmic residue was
severely affected [32].
CONCLUSIONS- The parameters selected to confirm the genotoxicity
of chewing leaf tobacco proved that chewing leaf tobacco at certain
concentration is genotoxic. Future research is required in unraveling the therapeutic
uses of chewing leaf tobacco in the field of chemotherapy because every
chemotherapeutic agents are highly genotoxic. They also produce cancers. This
chewing leaf tobacco, though a culprit in the society, clinically may be
useful, if the pharmacological properties are investigated and incorporated.
These Bioengineered Tobacco Plants may grow pharmaceuticals of the future.
Plant-derived medicines have been around forever, but until the development of
a process called biopharming, they've been restricted
to whatever naturally-occurring medicines the plants themselves could produce.
AKNOWLEDGEMENTS- The authors are very much thankful to their teacher and research supervisor (Late) Dr.
K.K. Vijayalaxmi for her
incessant support and blessings given in the true spirit of
professional recognition through the work.
REFERENCES
1.
Gebhardt C.
The historical role of species from the Solanaceae
plant family in genetic research. Theor Appl Genet, 2016; 129:2281–2294.
2.
Kunitz S.
J. Historical Influences on Contemporary Tobacco Use by Northern Plains and
Southwestern American Indians. American Journal of Public Health, 2016;
106(2):246–255.
3.
Charlton
A. Medicinal uses of tobacco in history. Journal of the Royal Society of
Medicine, 2004; 97:292-296.
4.
Begum
S,Schensul J J, Nair S, and Donta B.
Initiating smokeless tobacco use across reproductive stages. Asian Pac. J.
Cancer Prev, 2015; 16:7547–7554.
5.
Mishra GA,
Pimple S A, and Shastri S S.
An overview of the tobacco problem in India. Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian
Society of Medical & Paediatric Oncology, 2012;
33(3):139–145.
6.
Le Houezec J, McNeill A, and Britton J. Tobacco, nicotine and
harm reduction. Drug Alcohol Rev, 2011; 30:119-23.
7.
O’Connor
RJ. Non-cigarette tobacco products: what have we learnt and where are we
headed? Tobacco Control, 2012; 21:181-190.
8.
Luzhna L, Kathiria P,and Kovalchuk O. Micronuclei in genotoxicity
assessment: from genetics to epigenetics and beyond.
Frontiers in Genetics, 2013; 4(131):1-17.
9.
Hayashi
M. The micronucleus test- most widely used in vivo genotoxicity
test. Genes and Environment, 2016; 38(18):1-6.
10.
MacGregor JT,
Wehr CM, Henika R, and ShelbyMD. The In Vivo Erythrocyte Micronucleus Test:Measurement At Steady State Increases Assay Effficiency And Permits Integration With Toxicity Studies. Fundam.Appl.Toxicol, 1990; 14:513-522.
11.
Meistrich M
L. The Effects of Chemotherapy and Radiotherapy on Spermatogenesis in Humans.
Fertility and Sterility,2013; 100(5):1-14
12.
Vrooman L
A, Nagaoka S I, Hassold T J,
and Hunt P A. Evidence for Paternal Age-Related Alterations in Meiotic
Chromosome Dynamics in the Mouse. Genetics,2014; 196 (2): 385–396.
13.
Wosnitzer MS.
Genetic evaluation of male infertility. Translational Andrology
and Urology, 2014; 3(1):17–26.
14.
Poganitsch-Korhonen M, Masliukaite
I, Nurmio M, Lähteenmäki P,
Van Wely M, van Pelt AMM, Jahnukainen
K, Stukenborg JB. Decreased spermatogonial
quantity in prepubertal boys with leukaemia
treated with alkylating agents. Leukemia, 2017; 31:
1460-1463.
15.
Wyrobek AJ,
Gordon LA, Burkhart JG, Francis MW, Kapp RW Jr, Letz G, Malling
HG, Topham JC, Whorton MD.
An evaluation of the mouse sperm morphology test and other sperm tests in
non-human mammals. A report of the United States Environmental Protection
Agency Gene-Tox Programme.
1983; Mutat Res, 115:1-72.
16.
Das
S, Upadhaya P, and Giri S.
Arsenic and smokeless tobacco induce genotoxicity,
sperm abnormality as well as oxidative stress in mice in vivo. Genes and Environment, 2016; 38(4):1-8
17.
Sapra KJ,
Barr DB, Maisog JM, Sundaram
R, and Buck Louis GM. Time-topregnancy associated with Couples use of tobacco
products. Nicotine Tob Res, 2016; 18(11):2154–61.
18.
Kupradinum P, Tepsuwan A, and Kusamran WR. Anticlastogenic Effect of Asiatic Pennywort and Indian
Mulberry using Rodent Erythrocyte Micronucleus Assay. Thai J Vet Med, 2011;
41(1):87-94.
19.
Schlegel
R and MacGregor JT. The persistence of micronuclei in
peripheral blood erythrocytes: detection of chronic chromosome breakage in
mice. Mut. Res, 1982; 104:367-369.
20.
Mathew
G, Rahiman MA, and Vijayalaxmi
KK. In vivo genotoxic effects in mice of Metacid 50,
an organophosphorus insecticide. Mutagenesis, 1990;
5(2):147-149.
21.
Balmus G,
Karp NA, Ng B L, Jackson S P, Adams D J, and McIntyre R E. A high-throughput in
vivo micronucleus assay for genome instability screening in mice. Nature
Protocols, 2005; 10(1):205–215.
22.
Tice
R, Erexson G, Hilliard C, Huston J, Boehrn R, Guiati D K,and Shelby MD. Effect of treatment protocol and sample
time on frequencies cies of micronucleated
cells in mouse bone marrow and peripheral blood. Mutagenesis, 1990; 5:313-321.
23.
Bull
S, Fletcher K, Boobis A R, and Battershill
J M. Evidence for genotoxicity of pesticides in
pesticide applicators: a review. Mutagenesis, 2006; 21: 93–103.
24.
Gawish AM,
Issa AM, Aziza M A, and Ramadan S. Morphometrical, Histopathological,
and Cytogenetical ameliorating Effects of Green tea
extract on Nicotine Toxicity of the Testis of Rats. Journal of American
Science, 2010; 6(11):401-411.
25.
Schramke H,
Roemer E, Dempsey R, Hirter J, Meurrens
K, Berges A, Weiler H, Vanscheeuwijck P, and Schorp MK.
Toxicological assessment of kretek cigarettes. Part
7: the impact of ingredients added to kretek
cigarettes on inhalation toxicity. Regul Toxicol Pharmacol, 2014;
70(1):S81-9.
26.
Dalrymple A,
Ordonez P, Thorne D, Walker D, and Oscar M. Cigarette smoke induced genotoxicity and respiratory tract pathology: evidence to
support. Inhalation Toxicology, 2016; 28(7):324-338.
27.
Matter
BE and Grauwiler J. Micronuclei in mouse bone marrow
cells, a single in vivo model for the evaluation of drug induced chromosomal
aberrations. Mutat. Res, 1974; 23:239-249.
28.
Witt
KL, Livanos E, Kissling GE,
Torous D K, Caspary W, Tice
RR, and Recio
L. Comparison of Flow Cytometry and Microscopy-Based
Methods for Measuring Micronucleated Reticulocyte Frequencies in Rodents Treated with Nongenotoxic and Genotoxic Chemicals. Mutation Research,
2008; 649 (1-2):101–113.
29.
Gaur
DS, Talekar MS, and Pathak
V. Alcohol intake and cigarette smoking: Impact of two major lifestyle factors
on male fertility. Indian J Pathol Microbiol, 2010; 53:35-40.
30.
Vine
MF, Margolin BH, Morrison HI, and Hulka
BS. Cigarette smoking and sperm density: A meta analysis. Fertil
Steril, 1994; 61:35–43.
31.
Kumari A, Mojidra B, Gautam A, Verma Y, and Kumar
S. Reproductive toxic potential of panmasala in male
Swiss albino mice. Toxicol. Ind. Health, 2011;
27:683–690.
32.
Sunanda P,
Panda B, Dash C, Ray P K, Padhy R N, and Routray P. Prevalence of abnormal spermatozoa in tobacco
chewing sub-fertile males. Journal of Human Reproductive Sciences, 2014;
7(2):136–142.